Moi ML - Search Results

1

Yamamoto K, Matumoto K, Lim CK, Moi ML, Kotaki A, Takasaki T. Yamamoto K, et al. Among authors: moi ml. Intern Med. 2010;49(5):501-5. doi: 10.2169/internalmedicine.49.3027. Epub 2010 Mar 1. Intern Med. 2010. PMID: 20190493 Free article.

2

Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.

Nakamura Y, Moi ML, Shiina T, Shin-I T, Suzuki R. Nakamura Y, et al. Among authors: moi ml. Viruses. 2023 May 17;15(5):1186. doi: 10.3390/v15051186. Viruses. 2023. PMID: 37243272 Free PMC article.

3

Differential Infectivity of Human Neural Cell Lines by a Dengue Virus Serotype-3 Genotype-III with a Distinct Nonstructural Protein 2A (NS2A) Amino Acid Substitution Isolated from the Cerebrospinal Fluid of a Dengue Encephalitis Patient.

Phu Ly MH, Nguyen CT, Nguyen TV, Ngan Nguyen TT, Nabeshima T, Adungo F, Takamatsu Y, Huy NT, Mai Le TQ, Morita K, Hasebe F, Moi ML. Phu Ly MH, et al. Among authors: moi ml. Can J Infect Dis Med Microbiol. 2023 Jan 17;2023:2635383. doi: 10.1155/2023/2635383. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 36704099 Free PMC article.

4

Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.

Moi ML, Lim CK, Takasaki T, Kurane I. Moi ML, et al. J Gen Virol. 2010 Jan;91(Pt 1):103-11. doi: 10.1099/vir.0.014829-0. Epub 2009 Sep 23. J Gen Virol. 2010. PMID: 19776239

5

Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.

Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Moi ML, et al. J Virol Methods. 2010 Feb;163(2):205-9. doi: 10.1016/j.jviromet.2009.09.018. Epub 2009 Sep 23. J Virol Methods. 2010. PMID: 19781573

6

Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells.

Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Moi ML, et al. Clin Vaccine Immunol. 2010 Mar;17(3):402-7. doi: 10.1128/CVI.00396-09. Epub 2009 Dec 30. Clin Vaccine Immunol. 2010. PMID: 20042518 Free PMC article.

7

Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire.

Moi ML, Takasaki T, Kotaki A, Tajima S, Lim CK, Sakamoto M, Iwagoe H, Kobayashi K, Kurane I. Moi ML, et al. Emerg Infect Dis. 2010 Nov;16(11):1770-2. doi: 10.3201/eid1611.101061. Emerg Infect Dis. 2010. PMID: 21029541 Free PMC article.

8

Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection.

Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Moi ML, et al. J Infect Dis. 2011 May 15;203(10):1405-14. doi: 10.1093/infdis/jir053. J Infect Dis. 2011. PMID: 21502081 Free PMC article.

9

Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity.

Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I. Omatsu T, et al. Among authors: moi ml. J Gen Virol. 2011 Oct;92(Pt 10):2272-2280. doi: 10.1099/vir.0.031229-0. Epub 2011 Jun 22. J Gen Virol. 2011. PMID: 21697346

10

Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity.

Moi ML, Lim CK, Tajima S, Kotaki A, Saijo M, Takasaki T, Kurane I. Moi ML, et al. J Clin Virol. 2011 Nov;52(3):225-30. doi: 10.1016/j.jcv.2011.07.009. Epub 2011 Aug 6. J Clin Virol. 2011. PMID: 21824813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page